Full-Time

Pharmacist

Posted on 10/31/2025

Deadline 11/14/25
Cardinal Health

Cardinal Health

Distributes pharmaceuticals and medical products globally

Compensation Overview

$90.7k - $136.2k/yr

Company Does Not Provide H1B Sponsorship

Corpus Christi, TX, USA

In Person

Category
Medical, Clinical & Veterinary (3)
, ,
Requirements
  • Valid Pharmacist’s license in Texas, or able to obtain a valid license.
  • Must complete at least 200 hours of academic training in a nuclear pharmacy through an accredited program.
  • Ability to hear, write, and speak clearly in order to communicate with customers and health care professionals.
  • Strong customer service skills.
  • Manual dexterity required for occasional reach, lifting and holding of small objects.
  • Demonstrated manual dexterity in order to dispense doses.
  • Ability to manage weight up to 75 pounds.
  • Must hold a valid driver's license in the state in which the pharmacy is located.
  • Comfortable driving in all types of weather conditions (rain, sleet, snow, fog, wind and sun).
  • Deliveries occur during both nighttime and daytime conditions.
  • Flexibility to work various shifts or overtime as needed.
  • Intermediate computer skills (ability to use computers and tablets).
  • Ability to work weekends/holidays/on call or be in a rotation.
Responsibilities
  • Provides pharmaceutical care to patients as a staff pharmacist, including compounding of nuclear medications, testing for quality through chromatography, and directing distribution of medication using a team of drivers.
  • Assesses and maintains pharmacy inventory and executes necessary orders, including reviews, to maintain optimal supply and ongoing availability of drugs, identifying and procuring alternative drugs to mitigate risks, when necessary.
  • Leads processes for hiring of pharmacy staff, onboarding, and performance management, including leadership of competency evaluations process and documentation.
  • Manages and directs internal workflows of nuclear pharmacy, including optimization of staffing and scheduling to maintain best-in-class and streamlined pharmacy operations.
  • Assists in execution of plans for lowering costs, increasing efficiency and driving profitable growth to support strategic business objectives in the nuclear pharmacy business.
  • Maintains relationships with outside suppliers and vendors to understand availability of drug components and assist in demand planning.
  • Participates in administrative tasks to facilitate nuclear pharmacy operations, including interactions with customers.
Desired Qualifications
  • Bachelor’s degree in Pharmacy and/or PharmD preferred
  • Sterile Compounding Certification preferred
  • Working knowledge of biohazardous waste management procedures preferred
  • Prior Authorized User certification is preferred
  • Authorized User: As defined in part by the Nuclear Regulatory Commission, an individual who has completed a minimum of 700 hours of training in a structured educational program consisting of both didactic training and supervised on the job training in radiation physics, instrumentation, radiation protection, chemistry, math and radiation biology. This is usually divided into two sections: 200 hours of formal course work and 500 hours of supervised experience. For current pharmacists, the requirements are the same plus a preceptor statement of training from an Authorized Nuclear Pharmacist.

Cardinal Health distributes pharmaceuticals and manufactures medical and laboratory products for hospitals, clinics, and pharmacies worldwide. The company operates a global logistics network to deliver supplies while providing data tools that help healthcare facilities track inventory and improve operational efficiency. Unlike many niche suppliers, Cardinal Health combines 50 years of experience with a massive scale that covers both the physical supply chain and the software needed to manage it. Its goal is to streamline the healthcare supply chain to ensure providers have reliable access to essential products while reducing costs and improving patient care.

Company Size

N/A

Company Stage

N/A

Total Funding

$270.6M

Headquarters

Dublin, California

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • Majority stake in GI Alliance in November 2024 accelerates gastroenterology growth.
  • Acquired Advanced Diabetes Supply Group in November 2024 boosts at-Home Solutions.
  • Added Solaris Health urology MSO in August 2025 to Specialty Alliance platform.

What critics are saying

  • McKesson erodes specialty share with superior pharmacy analytics within 12-24 months.
  • Cencora undercuts generics pricing, squeezing margins in 6-12 months.
  • DEA quotas cut $500M opioid revenue comprising 20% sales in 3-6 months.

What makes Cardinal Health unique

  • Acquired Specialty Networks in January 2024 for multi-specialty GPOs in urology and gastroenterology.
  • Launched Kendall DL™ Multi System in June 2025 for continuous vital signs monitoring.
  • Expanded Actinium-225 production in April 2026 for novel cancer therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Health Savings Account/Flexible Spending Account

401(k) Retirement Plan

401(k) Company Match

Short- and Long-term Disability Coverage

Paid Parental Leave

Wellness Program

Company News

PR Newswire
Jan 31st, 2024
Cardinal Health To Acquire Specialty Networks And Its Pps Analytics Platform, A Technology Enabled Multi-Specialty Group Purchasing And Practice Enhancement Organization In Urology, Rheumatology And Gastroenterology

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices. Transaction creates platform for Cardinal Health expansion across specialty therapeutic areas. Transaction enhances capabilities of Cardinal Health Specialty and supports ongoing build of Navista™ NetworkDUBLIN, Ohio, Jan. 31, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization for $1.2B in cash. Specialty Networks creates clinical and economic value for independent specialty providers and partners across multiple specialty GPOs: UroGPO, Gastrologix and GastroGPO, and United Rheumatology

intelligence360
Mar 7th, 2023
Cardinal Health To Spend $3,100,000.00 To Occupy 3,794 Square Feet Of Space In Indianapolis Indiana.

Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana. Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana.Indianapolis, Indiana — According to state and local economic development sources, Cardinal Health plans to invest $3,100,000.00 to build out 3,794 square feet of new space in Indianapolis. The company plans to occupy the new space at 7736 Zionsville Rd in Indianapolis, on or about September 1, 2023. According to the company website Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled solutions to help our customers thrive in a changing world

GlobeNewswire
Jul 26th, 2022
RxLive Raises $5 Million Series A to Deliver Population Health Telepharmacy Solutions for At-Risk Patients

Digital Health Startup Is Tackling Medication Mismanagement, a $500 Billion Problem...

PR Newswire
Jan 10th, 2022
Medically Home Announces a $110 Million Strategic Investment Led by Baxter International Inc., Global Medical Response and Cardinal Health to Advance Leadership in Hospital-Level Patient Care at Home

/PRNewswire/ -- Medically Home today announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global...

INACTIVE